Zokinvy gets Japanese approval for Progeria treatment

The Progeria Research Foundation (PRF) has announced the Japanese approval of Zokinvy (lonafarnib) for treating Progeria and processing-deficient PL.

Related Keywords

Japan ,Boston ,Massachusetts ,United States ,Monica Kleinman ,Audrey Gordon ,Drug Administration ,Progeria Research Foundation ,Ministry Of Health ,European Medicines Administration ,Boston Children ,Hospital Progeria ,Research Foundation ,Eiger Biopharmaceuticals ,Hutchinson Gilford Progeria Syndrome ,